PTEN and cancer: In addition, as many as 4% of these individuals have germline pathogenic mutations in cancer predisposition genes other than BRCA1 and BRCA2 on MGPT (i.e. CHEK2, PALB2, ATM, NBN, PTEN, etc.)[27, 28].